Please assess the completion status of the following clinical trial:

Trial Title: Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects of either gender~* Age between 18 and 45 years~* Body mass index between 19 and 27kg/m2~* Normal medical history~* Normal or no clinically significant physical examination findings~* Normal or no clinically significant findings in analytical tests~* Negative hepatitis B, hepatitis C or HIV serology~* Negative drugs of abuse in urine~* Negative pregnancy test in females~* The subject understands and accepts the study procedures and grants in writing his/her informed consent~Exclusion Criteria:~* Did not fulfill the inclusion criteria~* Organic disorders or underwent major surgery, within 90 days before study screening~* Psychiatric history~* Alcohol drink intake greater than 30gr/day~* Cigarette smoking greater than 10 cigarettes/day~* Excessive consumption of food or beverages containing xanthines (more than five units of coffee, tea or cola per day)~* Medical treatment within 30 days before screening, and/or any medication 7 days before starting the study~* Participation in other clinical study or donate blood within 90 days before starting this study~* Antecedents of gastric, hepatic, renal and other kind of disorder that could affect ADME (absorption, distribution, metabolism or excretion of the study drug)~* Hepatitis B, hepatitis C or HIV positive serology~* Pregnant or breastfeeding~* Clinically relevant hypersensitivities (in particular to drugs)~* Woman taking oral contraceptive drugs~* Incapable of communicating and cooperating with investigators

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 Tramadol Contramid Once A Day (Type: EXPERIMENTAL): None
- 2 Zytram (R) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).